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ABSTRACT 
The design of co-crystals requires the knowledge of robust supramolecular synthons. The sulfoxide is a potent hydrogen bond acceptor and 
has been used as a co-crystal former with a range of NH functional groups, via N-H…O=S hydrogen bonds. The NH functional group 
retains favorable hydrogen bond motifs from its own structure in all cases where this is possible, with the sulfoxide interacting in a 
discrete, capping, fashion in four cases and in a bifurcated, bridging, fashion in the three other cases presented here. 
 
There is great interest in co-crystals in recent years, especially 
within the pharmaceutical arena.1 This is primarily because co-
crystals have the potential to alter and optimize physical 
properties such as crystalline form, solubility, and stability of an 
active pharmaceutical ingredient (API) without detrimentally 
affecting its activity.2 To date, most work has involved hydrogen 
bonds as the structure determining feature,1 although recent work 
has shown that weaker non-covalent interactions can also be 
used.3 
The design of co-crystals requires the knowledge of robust 
supramolecular synthons. The highly polar sulfoxide moiety, a 
potent hydrogen bond acceptor,4 attracted our attention as a 
powerful co-crystal former (co-former) with hydrogen bond 
donors. There are few reports of the sulfoxide functional group 
specifically as a co-crystal former: Nangia investigated co-
crystallization of trans-1,4-dithiane-1,4-dioxide,1i and Bernstein 
noted that diphenyl sulfoxide, 1a, does not tend to form co-
crystals.1e Indeed, a co-crystal with benzidine was only achieved 
when water was present in the lattice, which acted as a bridge 
between the N-H donor and the sulfoxide group, with N-H...O-
H...O=S hydrogen bonding.1e Related to these reports, research in 
the area of chiral resolution has also shown that hydrogen 
bonding involving the sulfoxide moiety as acceptor is possible, 
although the majority of the examples to date involve alcohols 
and carboxylic acids.1h,5 There have been reports of dipeptides 
interacting with the sulfoxide group via hydrogen bonding; 
interestingly, this has involved positively charged ammonium 
groups.6 In addition, Kagan showed that p-tolylmethyl-sulfoxide 
crystallizes with a chiral secondary amide, although the focus of 
this work is in asymmetric synthesis rather than in crystal 
engineering.7 
Herein we describe co-crystal formation of sulfoxides 1a and 
1b with a range of N-H containing compounds, Figure 1, and 
extension to a broader series is underway, including O-H donors.8 
In addition, the sulfoxide group is very poorly basic, and thus 
complications due to salt formation, via complete proton transfer 
from donor to an acceptor, are avoided. 
 
 
Figure 1. The co-formers investigated in this work. 
In this study co-crystals were prepared by two techniques: (i) 
solid-state grinding and (ii) slow growth from the solution phase. 
In all cases a 1:1 stoichiometry of 1 and 2 respectively was 
observed, except 3d, which has a 1:2 stoichiometry.9 
In all cases there is a decrease in the ν(SO) symmetric 
stretching frequency, from 1031 cm-1 and 1037 cm-1 for 1a and 1b 
respectively.9 Thus, in these cases IR is a viable screening tool for 
monitoring co-crystal formation. The largest shift, 33 cm-1, is seen 
for 3f and the smallest shift, 4 cm-1, for 3a. This shift can be 
explained by the hydrogen-bonded interaction between the donor 
hydrogen and the sulfoxide oxygen leading to a decrease in the 
SO bond order, and a corresponding decrease in the ν(SO) 
frequency. Similar effects have been seen for dilute solutions of 
DMSO in a variety of solvents.10 There is also an increase of 
20cm-1 in the ν(CO) frequency in 3f, indicative of an increase in 
the CO bond order. 
DSC experiments confirm co-crystal formation with one sharp 
endotherm evident in all cases.9 The mp for 3b, 3d-3g is lower 
than either co-crystal former. For 3a it is only 3 ºC above that of 
1b, whereas for 3c it is effectively the average of the two co-
formers. In a study of APIs Newman showed that 51% of co-
crystals have a mp between the two co-formers, whilst for 39% 
the mp was below that of either co-former, 6% were higher than 
either co-former  and 4% the same as one co-former.11 
In the solid state 2a,9 2b,12 2c,13 2d,14 2e15 and 2f16 form the 
hydrogen-bonded R 2 2 (8) dimers commonly observed in the solid 
state for carboxylic acids, primary amides and thioamides. The 
crystalline form of 2g exhibits C(4) chains and R 4 4 (14) tetramers 
giving rise to elegant layers parallel to the bc plane.17 
  
Polymorphism is known for 2b, 2c and 2e, with the R 2 2 (8) dimer 
motif present in all cases except the β form of 2b.12b 
Interestingly, the structures of the co-crystals 3a-3f reveal 
different motifs, despite the similar R 2 2 (8) dimers observed in the 
co-formers mentioned above. The co-crystals can be grouped into 
two categories: (i) the R 2 2 (8) dimers of the co-former are retained, 
with the sulfoxide capping the dimers and (ii) chains or discrete 
entities, with the sulfoxide capping the N-H donor, and the R 2 2 (8) 
dimer is lost. Specifically, 3a-3d all retain the R 2 2 (8) dimer. In 3a 
this results in a discrete 2 + 2 complex with the sulfoxide capping 
the free amide hydrogen, Figure 2. 
 
 
Figure 2. The R 2 2 (8) dimer in 3a, capped by the sulfoxide. 
The oxygen-based R 2 2 (8) dimer of the carboxylic acid in 3b is 
retained, and, in combination with R 2 4 (8) rings involving the 
aniline hydrogens and the sulfoxide oxygens, link the molecules 
into one-dimensional chains.9 
Thiourea, 2c, is well known to form channel clathrates,18 and 
the structure of 3c is fairly typical of such materials. Thus, the 
sulfoxide oxygen forms a bifurcated hydrogen-bond with the two 
hydrogens, anti to the sulfur atom, within the same molecule, 
effectively capping the side of the thiourea molecule opposite the 
sulfur atom, and allowing the remaining amide hydrogens to form 
a zig-zag linear motif of R 2 2 (8) rings in one-dimension.
9  
The cocrystal 3d is the only one in this work which showed a 
different stoichiometry (1:2) of sulfoxide to base: the reasons for 
this are unclear. The structure shows the sulfoxide is utilizing the 
amide hydrogens which are not part of the dimer motif and acting 
as a bridge between crystallographically distinct dimer pairs.9  
The second category, 3e-3g, involves disruption of the R 2 2 (8) 
dimer. Thus, for 3e the only hydrogen-bonded feature that is 
retained from the co-former, 2e, is the well known amide N-
H...O=C C(4) chain,19 see Figure 3. The amide hydrogen which is 
not involved in this chain is capped by the sulfoxide. Notably, the 
weak hydrogen bonds between the benzylic protons and the 
oxygen of dibenzyl sulfoxide, which are present in 1b,9,20 are also 
retained in this co-crystal. Such interactions have been shown to 
be structure directing in organosulfur compounds.20,21 
 
 
Figure 3. The N-H...C=O hydrogen bond leading to the C(4) chains in 
3e, with the individual units of the chain capped by the sulfoxide. 
As expected, the R 2 2 (8) dimer in 2f is not retained in 3f as 
hydrogen bonding between the single N-H and the strong 
sulfoxide acceptor overcomes the N-H...O=C seen in 2f, and the 
sulfoxide caps the N-H in a discrete fashion.9 As the C=O bond is 
no longer involved in hydrogen bonding, an  increase in the C=O 
bond order and ν(CO) frequency is seen as mentioned above. 
While co-former 2g is the only compound studied which does 
not exhibit a dimer motif, interestingly the structure of 3g is 
similar to the other co-crystals. There is a N-H...O=S C(4) chain 
linking the sulfonamide molecules, which is retained from the 
structure of 2e, with the sulfoxide capping the remaining 
hydrogen, in a similar fashion to 3e.9 
For all structures there are no significant differences in the S=O 
bond distance between the sulfoxide co-former9,20,22 and the 
sulfoxide in the co-crystals, despite the observed changes in the 
ν(SO) frequencies. 
As mentioned in the introduction, the sulfoxide group has been 
shown to interact via hydrogen bonding with alcohols and 
carboxylic acids,1h,1i,5 as well as with the positively charged 
ammonium group.6 In view of the report by Bernstein that 1a does 
not tend to form co-crystals,1e it is particularly significant that we 
have shown sulfoxides acting as a general co-former with a series 
of NH compounds ranging from amines, (thio)amides, 
sulfonamides, thiourea etc. Critically, N-H...O=S hydrogen 
bonding is a key component of these structures, in direct contrast 
with Bernstein's observation that water was required to bridge the 
two components.   
Interestingly, for six of the seven co-crystals key structure 
determining hydrogen bond motifs are retained from the co-
former, whilst this is not possible for the seventh, 3f. The R 2 2 (8) 
dimer is retained in four cases, and C(4) chains retained in a 
further two. The sulfoxide is bifurcated in three cases when the 
dimer is retained, and acts in a discrete fashion in all other cases. 
Further work is underway to gain a fuller understanding of the 
influence of the sulfoxide on the final hydrogen bonded motifs 
found in the co-crystals. 
In conclusion, the potent hydrogen bonding acceptor ability of 
sulfoxides render them excellent co-formers with a wide variety of 
N-H donors. Notably, co-crystallization with sulfoxides is not 
complicated by proton transfer and salt formation since they are 
poorly basic, as exemplified by formation of cocrystal 3f 
containing the relatively acidic saccharin, which displays a high 
propensity for salt formation in the solid state. Preliminary results 
have been obtained using sulfoxides as co-formers with phenols 
and sulfonic acids, among other groups, which will be published 
in due course. 
As the sulfoxide functionality is common in a significant 
number of APIs, this fundamental exploration into its ability as a 
co-former may well lead to improvements in drug development. 
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